Sullivan Lynne Marie

Sullivan Lynne Marie is listed in filings as Director at Inozyme Pharma, Inc.. This profile follows SEC Form 4 activity through Jul 3, 2025, including 2 public disclosures. Recent filings connect the profile to Inozyme Pharma, Inc. (INZY). The current snapshot covers public activity from Jun 20, 2024 to Jul 3, 2025. Reported amounts are shown as $78.6K to $123.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.